Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia

Critical Care Medicine

Volumn 31, Issue 3, 2003, Pages 929-932

  Opal, Steven M ^a,c   Palardy, John E ^a   Parejo, Nicolas ^a   Jasman, Richard L ^b  

^a BROWN UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

Bacteremia Escherichia coli; CD14; Endotoxin; Sepsis; Septic shock

Indexed keywords

CEFTAZIDIME; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD14; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BACTEREMIA; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIUM CULTURE; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; BACTEREMIA; CEFTAZIDIME; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUG MONITORING; DRUG THERAPY, COMBINATION; ENDOTOXINS; ESCHERICHIA COLI INFECTIONS; FEMALE; LIVER; LUNG; PROSPECTIVE STUDIES; RABBITS; RANDOM ALLOCATION; SPLEEN; TIME FACTORS;

EID: 0037348959     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000054870.25767.EE     Document Type: Article

References (17)

1. Wright SD: CD14 and innate recognition of bacteria. J Immunol 1995; 155:6-8
2. Dziarski R, Viriyakosol S, Kirkland TN, et al: Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: Structure requirements differ from those for responses to lipopolysaccharide. Infect Immun 2000; 68:5254-5260
3. Pugin J, Heumann ID, Tomasz A, et al: CD14 is a pattern recognition receptor. Immunity 1994; 1:509-514
4. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activations of adaptive immunity. Nature 1997; 388:394-398
5. Poltorak A, He X, Smirnova I, et al: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in the Tlr4 gene. Science 1998; 282:2085-2088
6. Takeuchi O, Hoshino K, Kawai T, et al: Differential roles of Tlr2 and Tlr4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443-451
7. Lien E, Sellati TJ, Yoshimura A, et al: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274:33419-33425
8. Means TK, Golenboch DT, Fenton MJ: The biology of Toll-like receptors. Cytokine Growth Factor Rev 2000; 11:219-232
9. Jersmann HP, Hii CS, Hodge GL, et al: Synthesis and surface expression of CD14 by human endothelial cells. Infect Immun 2001; 69:479-485
10. Leturcq DJ, Moriaty AM, Talbott G, et al: Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996; 98:1533-1538
11. Haziot A, Ferrero E, Kontgen F, et al: Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4:407-412
12. Schimke J, Mathison J, Morgiewicz J, et al: Anti-CD14 mAb provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci U S A 998; 95:13875-13880
13. Frevert CW, Matute-Bello G, Skerrett SJ, et al: Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol 2000; 164:5439-5445
14. Wenneras C, Ave P, Huerre M, et al: Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. J Immunol 2000; 164:3214-3221
15. Gemski P, Cross AS, Sadoff JC: K1 antigenassociated resistance to the bactericidal activity of serum. FEMS Microbiol Lett 1980; 9:193-197
16. Simpson AJH, Opal SM, Angus BJ, et al. Differential antibiotic-induced endotoxin release in severe melioidosis. J Infect Dis 2000; 181:1014-019
17. LeRoy OD, Padova F, Adachi Y, et al: Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against Gram-negative bacteria. J Immunol 2001; 167:2759-2765